Article info
PDFEditorial
A guide to poly ADP-ribose polymerase inhibitor (PARPi) toxicity management
- Correspondence to Dr Donyika Ann Joseph, Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston TX 77030, Texas, USA; djoseph2{at}mdanderson.org
Citation
A guide to poly ADP-ribose polymerase inhibitor (PARPi) toxicity management
Publication history
- Received May 15, 2020
- Accepted May 19, 2020
- First published May 30, 2020.
Article Versions
- You are currently viewing a Previous version of this article (6 July 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.